PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot
Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.
Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.
Also available in podcast format:
Listen to “PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – An Interview with Tadeusz Hawrot” on Spreaker.The topics in this episode:
- Introduction to PAREA
- Why is Europe Lagging Behind the USA in Psychedelic Science?
- Which Psychedelic Substances Have the Greatest Potential to Become Medicines in the EU?
- Is There Potential in National Legislation, Such as in the Czech Republic?
- What Should Be Done About the Grey Areas of Psychedelic Treatment?
- How Can Professionals Be Trained in Psychedelic Treatment?
Interview: Péter Sárosi
Video: István Gábor Takács
